Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor

Oncogene

Volumn 31, Issue 42, 2012, Pages 4536-4549

  Germann, S ^a,b,c,d   Gratadou, L ^a,b,c,d   Zonta, E ^a,b,c,d   Dardenne, E ^a,b,c,d   Gaudineau, B ^e   Fougere M ^e   Samaan, S ^a,b,c,d   Dutertre, M ^a,b,c,d   Jauliac, S ^e   Auboeuf, D ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CNRS   (France)

Author keywords

cancer; ddx17; ddx5; NFAT5; splicing; transcriptional coregulator

Indexed keywords

MESSENGER RNA; RNA HELICASE; RNA HELICASE DDX17; RNA HELICASE DDX5; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT5; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL MIGRATION; CODON; CONTROLLED STUDY; EXON; GENE TARGETING; HUMAN; HUMAN CELL; NFAT5 ONCOGENE; NONSENSE MEDIATED MRNA DECAY; ONCOGENE; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSLATION REGULATION; TUMOR CELL;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; DEAD-BOX RNA HELICASES; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MCF-7 CELLS; MICE; MYOBLASTS; NFATC TRANSCRIPTION FACTORS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84867745553     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.618     Document Type: Article

References (75)

1. Allemand E, Batsche E, Muchardt C. (2008). Splicing, transcription, and chromatin: a menage a trois. Curr Opin Genet Dev 18: 145-151.
2. Auboeuf D, Batsche E, Dutertre M, Muchardt C, O'Malley BW. (2007). Coregulators: transducing signal from transcription to alternative splicing. Trends Endocrinol Metab 18: 122-129.
3. Auboeuf D, Honig A, Berget SM, O'Malley BW. (2002). Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298: 416-419.
4. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K et al. (2004). Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22: 2284-2293.
5. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE et al. (2002). NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10: 1071-1081.
6. Barbier J, Dutertre M, Bittencourt D, Sanchez G, Gratadou L, de la Grange P et al. (2007). Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways. Mol Cell Biol 27: 7315-7333.
7. Bates GJ, Nicol SM, Wilson BJ, Jacobs AM, Bourdon JC, Wardrop J et al. (2005). The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. Embo J 24: 543-553.
8. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS et al. (2004). Ultraconserved elements in the human genome. Science 304: 1321-1325.
9. Bittencourt D, Dutertre M, Sanchez G, Barbier J, Gratadou L, Auboeuf D. (2008). Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes. Mol Cell Biol 28: 5811-5824.
10. Blencowe BJ. (2003). Splicing regulation: the cell cycle connection. Curr Biol 13: R149-R151.
11. Burg MB, Ferraris JD, Dmitrieva NI. (2007). Cellular response to hyperosmotic stresses. Physiol Rev 87: 1441-1474.
12. Camats M, Guil S, Kokolo M, Bach-Elias M. (2008). P68 RNA helicase (DDX5) alters activity of cis-and trans-acting factors of the alternative splicing of H-Ras. PLoS One 3: e2926.
13. Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V et al. (2006). The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell 11: 547-560.
14. Carter CL, Lin C, Liu CY, Yang L, Liu ZR. (2010). Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter. Oncogene 29: 5427-5436.
15. Causevic M, Hislop RG, Kernohan NM, Carey FA, Kay RA, Steele RJ et al. (2001). Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20: 7734-7743.
16. Chang YF, Chan WK, Imam JS, Wilkinson MF. (2007). Alternatively spliced T-cell receptor transcripts are up-regulated in response to disruption of either splicing elements or reading frame. J Biol Chem 282: 29738-29747.
17. Chen M, Sastry SK, O'Connor KL. (2011). Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells. Am J Physiol Cell Physiol 300: C1155-C1163.
18. Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL. (2009). Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem 284: 1484-1494.
19. Chen Y, Schnetz MP, Irarrazabal CE, Shen RF, Williams CK, Burg MB et al. (2007). Proteomic identification of proteins associated with the osmoregulatory transcription factor TonEBP/OREBP: functional effects of Hsp90 and PARP-1. Am J Physiol Renal Physiol 292: F981-F992.
20. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK et al. (2002). Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16: 881-895.
21. Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S et al. (2008). The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res 68: 7938-7946.
22. Dahl SC, Handler JS, Kwon HM. (2001). Hypertonicity-induced phosphorylation and nuclear localization of the transcription factor TonEBP. Am J Physiol Cell Physiol 280: C248-C253.
23. Dalski A, Hebinck A, Winking H, Butzmann U, Schwinger E, Zuhlke C. (2002). Complete cDNA sequence, expression, alternative splicing, and genomic organization of the mouse Nfat5 gene. Cytogenet Genome Res 97: 179-182.
24. David CJ, Manley JL. (2010). Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24: 2343-2364.
25. Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R. (1996). Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1631-1637.
26. Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R et al. (2010a). Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res 70: 3760-3770.
27. Dutertre M, Vagner S, Auboeuf D. (2010b). Alternative splicing and breast cancer. RNA Biol 7: 403-411.
28. Ferraris JD, Williams CK, Persaud P, Zhang Z, Chen Y, Burg MB. (2002). Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration. Proc Natl Acad Sci USA 99: 739-744.
29. Flower DR. (1994). The lipocalin protein family: a role in cell regulation. FEBS Lett 354: 7-11.
30. Fougere M, Gaudineau B, Barbier J, Guaddachi F, Feugeas JP, Auboeuf D et al. (2010). NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene 29: 2292-2301.
31. Friedl P, Wolf K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
32. Fuller-Pace FV, Ali S. (2008). The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators. Biochem Soc Trans 36: 609-612.
33. Fuller-Pace FV, Moore HC. (2011). RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development. Future Oncol 7: 239-251.
34. Gardner LB. (2010). Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol Cancer Res 8: 295-308.
35. Garrett SC, Varney KM, Weber DJ, Bresnick AR. (2006). S100A4, a mediator of metastasis. J Biol Chem 281: 677-680.
36. Guil S, Gattoni R, Carrascal M, Abian J, Stevenin J, Bach-Elias M. (2003). Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol Cell Biol 23: 2927-2941.
37. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
38. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. (2005). The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92: 1955-1958.
39. Honig A, Auboeuf D, Parker MM, O'Malley BW, Berget SM. (2002). Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol Cell Biol 22: 5698-5707.
40. Irarrazabal CE, Gallazzini M, Schnetz MP, Kunin M, Simons BL, Williams CK et al. (2010). Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP. Proc Natl Acad Sci USA 107: 906-911.
41. Jacobs AM, Nicol SM, Hislop RG, Jaffray EG, Hay RT, Fuller-Pace FV. (2007). SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 26: 5866-5876.
42. Janknecht R. (2010). Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am J Transl Res 2: 223-234.
43. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A. (2002). The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540-544.
44. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X et al. (2011). RNA Helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5 splice site. Mol Cell Biol 31: 1812-1821.
45. Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J et al. (2009). Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 69: 8579-8584.
46. Leng X, Wu Y, Arlinghaus RB. (2011). Relationships of lipocalin 2 with breast tumorigenesis and metastasis. J Cell Physiol 226: 309-314.
47. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S et al. (2010). Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 40: 841-849.
48. Lewis BP, Green RE, Brenner SE. (2003). Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 100: 189-192.
49. Li ZH, Bresnick AR. (2006). The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 66: 5173-5180.
50. Lopez-Rodriguez C, Aramburu J, Jin L, Rakeman AS, Michino M, Rao A. (2001). Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15: 47-58.
51. Macian F. (2005). NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.
52. Mancini M, Toker A. (2009). NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 9: 810-820.
53. Maouyo D, Kim JY, Lee SD, Wu Y, Woo SK, Kwon HM. (2002). Mouse TonEBP-NFAT5: expression in early development and alternative splicing. Am J Physiol Renal Physiol 282: F802-F809.
54. McGlincy NJ, Smith CW. (2008). Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 33: 385-393.
55. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
56. Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R. (2010a). Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem 285: 30443-30452.
57. Mooney SM, Grande JP, Salisbury JL, Janknecht R. (2010b). Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49: 1-10.
58. Moore HC, Jordan LB, Bray SE, Baker L, Quinlan PR, Purdie CA et al. (2010). The RNA helicase p68 modulates expression and function of the Delta133 isoform(s) of p53, and is inversely associated with Delta133p53 expression in breast cancer. Oncogene 29: 6475-6484.
59. Muller MR, Rao A. (2010). NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10: 645-656.
60. Neu-Yilik G, Kulozik AE. (2008). NMD: multitasking between mRNA surveillance and modulation of gene expression. Adv Genet 62: 185-243.
61. O'Connor RS, Mills ST, Jones KA, Ho SN, Pavlath GK. (2007). A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J Cell Sci 120: 149-159.
62. Rossow KL, Janknecht R. (2003). Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene 22: 151-156.
63. Shin S, Rossow KL, Grande JP, Janknecht R. (2007). Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res 67: 7572-7578.
64. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D et al. (2005). Function of alternative splicing. Gene 344: 1-20.
65. Warner DR, Bhattacherjee V, Yin X, Singh S, Mukhopadhyay P, Pisano MM et al. (2004). Functional interaction between Smad, CREB binding protein, and p68 RNA helicase. Biochem Biophys Res Commun 324: 70-76.
66. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S et al. (2010). An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. Embo J 29: 3286-3300.
67. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y et al. (2001). A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. Embo J 20: 1341-1352.
68. Wilson BJ, Bates GJ, Nicol SM, Gregory DJ, Perkins ND, Fuller-Pace FV. (2004). The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol 5: 11.
69. Woo SK, Dahl SC, Handler JS, Kwon HM. (2000). Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity. Am J Physiol Renal Physiol 278: F1006-F1012.
70. Wortham NC, Ahamed E, Nicol SM, Thomas RS, Periyasamy M, Jiang J et al. (2009). The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene 28: 4053-4064.
71. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL et al. (2009). Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 106: 3913-3918.
72. Yang L, Lin C, Liu ZR. (2005). Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol Cancer Res 3: 355-363.
73. Yang L, Lin C, Liu ZR. (2006). P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 127: 139-155.
74. Yang L, Lin C, Zhao S, Wang H, Liu ZR. (2007). Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression. J Biol Chem 282: 16811-16819.
75. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539-550.